IHC analysis of CXCR3 using anti-CXCR3 antibody (PB9079).
Anti-CXCR3 Antibody Picoband(r)
PB9079
ApplicationsWestern Blot, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Rat
TargetCXCR3
Overview
- SupplierBoster Bio
- Product NameAnti-CXCR3 Picoband Antibody
- Delivery Days Customer9
- Antibody SpecificityNo cross reactivity with other proteins.
- Application Supplier NoteWB: The detection limit for CXCR3 is approximately 0.25ng/lane under reducing conditions. Tested Species: In-house tested species with positive results. By Heat: Boiling the paraffin sections in 10mM citrate buffer, pH6.0, for 20mins is required for the staining of formalin/paraffin sections. Other applications have not been tested. Optimal dilutions should be determined by end users.
- ApplicationsWestern Blot, ImmunoHistoChemistry
- Applications SupplierIHP, WB, IHC
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration500 ug/ml
- FormulationLyophilized
- Gene ID2833
- Target nameCXCR3
- Target descriptionC-X-C motif chemokine receptor 3
- Target synonymsCD182; CD183; chemokine (C-X-C motif) receptor 3; chemokine receptor 3; CKR-L2; CMKAR3; C-X-C chemokine receptor type 3; G protein-coupled receptor 9; GPR9; interferon-inducible protein 10 receptor; IP-10 receptor; IP10-R; Mig receptor; MigR; Mig-R
- HostRabbit
- IsotypeIgG
- Protein IDP49682
- Protein NameC-X-C chemokine receptor type 3
- Scientific DescriptionBoster Bio Anti-CXCR3 Antibody Picoband® catalog # PB9079. Tested in IHC, WB applications. This antibody reacts with Human, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
- ReactivityHuman, Rat
- Reactivity SupplierHuman, Rat
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203
References
- CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways. Chen X et al., 2021, Front OncolRead more